N-(4'-Isonicotinimidoylamino-biphenyl-4-yl)-isonicotinamidine

ID: ALA2311587

PubChem CID: 71569230

Max Phase: Preclinical

Molecular Formula: C24H20N6

Molecular Weight: 392.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(Nc1ccc(-c2ccc(NC(=N)c3ccncc3)cc2)cc1)c1ccncc1

Standard InChI:  InChI=1S/C24H20N6/c25-23(19-9-13-27-14-10-19)29-21-5-1-17(2-6-21)18-3-7-22(8-4-18)30-24(26)20-11-15-28-16-12-20/h1-16H,(H2,25,29)(H2,26,30)

Standard InChI Key:  PBJNRDGELJSZLT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   12.5821  -25.1065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0072  -24.4058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6130  -23.6894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7939  -23.6725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3706  -24.3779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7672  -25.0914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5535  -24.3644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1567  -23.6500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1332  -25.0652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9970  -22.2180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5819  -22.9246    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9862  -23.6353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8055  -23.6406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2188  -22.9293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8121  -22.2215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0359  -22.9312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4428  -23.6399    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4462  -22.2245    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2600  -23.6419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6638  -24.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4803  -24.3550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8914  -23.6478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4801  -22.9367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6650  -22.9379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7057  -23.6465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1129  -24.3563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9293  -24.3575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3395  -23.6497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9273  -22.9392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1122  -22.9415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 14 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 22 25  1  0
 28  8  1  0
M  END

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PA-1 (704 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

COS-1 (266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.47Molecular Weight (Monoisotopic): 392.1749AlogP: 5.02#Rotatable Bonds: 5
Polar Surface Area: 97.54Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.00CX LogP: 3.39CX LogD: 2.45
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.28Np Likeness Score: -0.51

References

1. Arya S, Kumar N, Roy P, Sondhi SM..  (2013)  Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity.,  59  [PMID:23202484] [10.1016/j.ejmech.2012.10.046]

Source